Stemmatters is a biotechnology company focused on regenerative medicine.


Stemmatters has therapeutic development programs in cartilage repair, osteoarthritis management and spinal cord injury repair. The company also provides contract manufacturing services regarding tissue processing, manufacturing (cells and cell based products), and stem cell banking.


Stemmatters is registered as SME with EMA since 2012.


To become a global enabler of regenerative medicine by offering 

integrated manufacturing solutions and novel platforms for cellular based products.


Our mission is to provide customized manufacturing and novel regenerative medicine products that help people counteracting degenerative and traumatic medical conditions.

Stemmatters @ BIO Europe Spring 2015
(read more)
Stemmatters @ BIO International Convention, Illinois Chicago
(read more)
EROMED, European Regulation of Medical Devices Seminars @ University of Minho, 11th Dec 14
(read more)